Head And Neck Squamous Cell Carcinoma Treatment Market, Global Outlook and Forecast 2022-2028

April 2022 | 62 pages | ID: HC9A6E50DCD3EN
Market Monitor Global

Abstracts

Head and neck squamous cell carcinoma is the sixth leading cancer worldwide by incidence. Head and neck squamous cell carcinoma progresses from the mucosal membrane, comprising the paranasal sinuses and nasal cavity, the nasopharynx, the hypopharynx, larynx, and trachea, and the oropharynx and oral cavity. According to WHO, The annual incidence of head and neck squamous cell carcinoma worldwide is more than 550,000 cases with around 300,000 deaths every year. Alcohol and tobacco is the risk factor for head and neck squamous cell carcinoma. Five years survival rate of patients with head and neck squamous cell carcinoma is about 40-50%.

This report contains market size and forecasts of Head And Neck Squamous Cell Carcinoma Treatment in Global, including the following market information:

Global Head And Neck Squamous Cell Carcinoma Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Head And Neck Squamous Cell Carcinoma Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Surgical Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Head And Neck Squamous Cell Carcinoma Treatment include Amgen, AbbVie, Bristol-Myers Squibb, AstraZeneca, Eli Lilly, GlaxoSmithKline, Teva, Roche and Celgene. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Head And Neck Squamous Cell Carcinoma Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Head And Neck Squamous Cell Carcinoma Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Head And Neck Squamous Cell Carcinoma Treatment Market Segment Percentages, by Type, 2021 (%)

• Surgical Therapy
• Radiation Therapy
• Drug Treatment

Global Head And Neck Squamous Cell Carcinoma Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Head And Neck Squamous Cell Carcinoma Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics
• Ambulatory Surgical Centers

Global Head And Neck Squamous Cell Carcinoma Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Head And Neck Squamous Cell Carcinoma Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Head And Neck Squamous Cell Carcinoma Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Head And Neck Squamous Cell Carcinoma Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Amgen
• AbbVie
• Bristol-Myers Squibb
• AstraZeneca
• Eli Lilly
• GlaxoSmithKline
• Teva
• Roche
• Celgene

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Head And Neck Squamous Cell Carcinoma Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Head And Neck Squamous Cell Carcinoma Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL HEAD AND NECK SQUAMOUS CELL CARCINOMA TREATMENT OVERALL MARKET SIZE

2.1 Global Head And Neck Squamous Cell Carcinoma Treatment Market Size: 2021 VS 2028
2.2 Global Head And Neck Squamous Cell Carcinoma Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Head And Neck Squamous Cell Carcinoma Treatment Players in Global Market
3.2 Top Global Head And Neck Squamous Cell Carcinoma Treatment Companies Ranked by Revenue
3.3 Global Head And Neck Squamous Cell Carcinoma Treatment Revenue by Companies
3.4 Top 3 and Top 5 Head And Neck Squamous Cell Carcinoma Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Head And Neck Squamous Cell Carcinoma Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Head And Neck Squamous Cell Carcinoma Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Head And Neck Squamous Cell Carcinoma Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Head And Neck Squamous Cell Carcinoma Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Head And Neck Squamous Cell Carcinoma Treatment Market Size Markets, 2021 & 2028
  4.1.2 Surgical Therapy
  4.1.3 Radiation Therapy
  4.1.4 Drug Treatment
4.2 By Type - Global Head And Neck Squamous Cell Carcinoma Treatment Revenue & Forecasts
  4.2.1 By Type - Global Head And Neck Squamous Cell Carcinoma Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Head And Neck Squamous Cell Carcinoma Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Head And Neck Squamous Cell Carcinoma Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Head And Neck Squamous Cell Carcinoma Treatment Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Clinics
  5.1.4 Ambulatory Surgical Centers
5.2 By Application - Global Head And Neck Squamous Cell Carcinoma Treatment Revenue & Forecasts
  5.2.1 By Application - Global Head And Neck Squamous Cell Carcinoma Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Head And Neck Squamous Cell Carcinoma Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Head And Neck Squamous Cell Carcinoma Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Head And Neck Squamous Cell Carcinoma Treatment Market Size, 2021 & 2028
6.2 By Region - Global Head And Neck Squamous Cell Carcinoma Treatment Revenue & Forecasts
  6.2.1 By Region - Global Head And Neck Squamous Cell Carcinoma Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Head And Neck Squamous Cell Carcinoma Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Head And Neck Squamous Cell Carcinoma Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Head And Neck Squamous Cell Carcinoma Treatment Revenue, 2017-2028
  6.3.2 US Head And Neck Squamous Cell Carcinoma Treatment Market Size, 2017-2028
  6.3.3 Canada Head And Neck Squamous Cell Carcinoma Treatment Market Size, 2017-2028
  6.3.4 Mexico Head And Neck Squamous Cell Carcinoma Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Head And Neck Squamous Cell Carcinoma Treatment Revenue, 2017-2028
  6.4.2 Germany Head And Neck Squamous Cell Carcinoma Treatment Market Size, 2017-2028
  6.4.3 France Head And Neck Squamous Cell Carcinoma Treatment Market Size, 2017-2028
  6.4.4 U.K. Head And Neck Squamous Cell Carcinoma Treatment Market Size, 2017-2028
  6.4.5 Italy Head And Neck Squamous Cell Carcinoma Treatment Market Size, 2017-2028
  6.4.6 Russia Head And Neck Squamous Cell Carcinoma Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Head And Neck Squamous Cell Carcinoma Treatment Market Size, 2017-2028
  6.4.8 Benelux Head And Neck Squamous Cell Carcinoma Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Head And Neck Squamous Cell Carcinoma Treatment Revenue, 2017-2028
  6.5.2 China Head And Neck Squamous Cell Carcinoma Treatment Market Size, 2017-2028
  6.5.3 Japan Head And Neck Squamous Cell Carcinoma Treatment Market Size, 2017-2028
  6.5.4 South Korea Head And Neck Squamous Cell Carcinoma Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Head And Neck Squamous Cell Carcinoma Treatment Market Size, 2017-2028
  6.5.6 India Head And Neck Squamous Cell Carcinoma Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Head And Neck Squamous Cell Carcinoma Treatment Revenue, 2017-2028
  6.6.2 Brazil Head And Neck Squamous Cell Carcinoma Treatment Market Size, 2017-2028
  6.6.3 Argentina Head And Neck Squamous Cell Carcinoma Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Head And Neck Squamous Cell Carcinoma Treatment Revenue, 2017-2028
  6.7.2 Turkey Head And Neck Squamous Cell Carcinoma Treatment Market Size, 2017-2028
  6.7.3 Israel Head And Neck Squamous Cell Carcinoma Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Head And Neck Squamous Cell Carcinoma Treatment Market Size, 2017-2028
  6.7.5 UAE Head And Neck Squamous Cell Carcinoma Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Amgen
  7.1.1 Amgen Corporate Summary
  7.1.2 Amgen Business Overview
  7.1.3 Amgen Head And Neck Squamous Cell Carcinoma Treatment Major Product Offerings
  7.1.4 Amgen Head And Neck Squamous Cell Carcinoma Treatment Revenue in Global Market (2017-2022)
  7.1.5 Amgen Key News
7.2 AbbVie
  7.2.1 AbbVie Corporate Summary
  7.2.2 AbbVie Business Overview
  7.2.3 AbbVie Head And Neck Squamous Cell Carcinoma Treatment Major Product Offerings
  7.2.4 AbbVie Head And Neck Squamous Cell Carcinoma Treatment Revenue in Global Market (2017-2022)
  7.2.5 AbbVie Key News
7.3 Bristol-Myers Squibb
  7.3.1 Bristol-Myers Squibb Corporate Summary
  7.3.2 Bristol-Myers Squibb Business Overview
  7.3.3 Bristol-Myers Squibb Head And Neck Squamous Cell Carcinoma Treatment Major Product Offerings
  7.3.4 Bristol-Myers Squibb Head And Neck Squamous Cell Carcinoma Treatment Revenue in Global Market (2017-2022)
  7.3.5 Bristol-Myers Squibb Key News
7.4 AstraZeneca
  7.4.1 AstraZeneca Corporate Summary
  7.4.2 AstraZeneca Business Overview
  7.4.3 AstraZeneca Head And Neck Squamous Cell Carcinoma Treatment Major Product Offerings
  7.4.4 AstraZeneca Head And Neck Squamous Cell Carcinoma Treatment Revenue in Global Market (2017-2022)
  7.4.5 AstraZeneca Key News
7.5 Eli Lilly
  7.5.1 Eli Lilly Corporate Summary
  7.5.2 Eli Lilly Business Overview
  7.5.3 Eli Lilly Head And Neck Squamous Cell Carcinoma Treatment Major Product Offerings
  7.5.4 Eli Lilly Head And Neck Squamous Cell Carcinoma Treatment Revenue in Global Market (2017-2022)
  7.5.5 Eli Lilly Key News
7.6 GlaxoSmithKline
  7.6.1 GlaxoSmithKline Corporate Summary
  7.6.2 GlaxoSmithKline Business Overview
  7.6.3 GlaxoSmithKline Head And Neck Squamous Cell Carcinoma Treatment Major Product Offerings
  7.6.4 GlaxoSmithKline Head And Neck Squamous Cell Carcinoma Treatment Revenue in Global Market (2017-2022)
  7.6.5 GlaxoSmithKline Key News
7.7 Teva
  7.7.1 Teva Corporate Summary
  7.7.2 Teva Business Overview
  7.7.3 Teva Head And Neck Squamous Cell Carcinoma Treatment Major Product Offerings
  7.7.4 Teva Head And Neck Squamous Cell Carcinoma Treatment Revenue in Global Market (2017-2022)
  7.7.5 Teva Key News
7.8 Roche
  7.8.1 Roche Corporate Summary
  7.8.2 Roche Business Overview
  7.8.3 Roche Head And Neck Squamous Cell Carcinoma Treatment Major Product Offerings
  7.8.4 Roche Head And Neck Squamous Cell Carcinoma Treatment Revenue in Global Market (2017-2022)
  7.8.5 Roche Key News
7.9 Celgene
  7.9.1 Celgene Corporate Summary
  7.9.2 Celgene Business Overview
  7.9.3 Celgene Head And Neck Squamous Cell Carcinoma Treatment Major Product Offerings
  7.9.4 Celgene Head And Neck Squamous Cell Carcinoma Treatment Revenue in Global Market (2017-2022)
  7.9.5 Celgene Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Head And Neck Squamous Cell Carcinoma Treatment Market Opportunities & Trends in Global Market
Table 2. Head And Neck Squamous Cell Carcinoma Treatment Market Drivers in Global Market
Table 3. Head And Neck Squamous Cell Carcinoma Treatment Market Restraints in Global Market
Table 4. Key Players of Head And Neck Squamous Cell Carcinoma Treatment in Global Market
Table 5. Top Head And Neck Squamous Cell Carcinoma Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Head And Neck Squamous Cell Carcinoma Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Head And Neck Squamous Cell Carcinoma Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Head And Neck Squamous Cell Carcinoma Treatment Product Type
Table 9. List of Global Tier 1 Head And Neck Squamous Cell Carcinoma Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Head And Neck Squamous Cell Carcinoma Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Head And Neck Squamous Cell Carcinoma Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Head And Neck Squamous Cell Carcinoma Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Head And Neck Squamous Cell Carcinoma Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Head And Neck Squamous Cell Carcinoma Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Head And Neck Squamous Cell Carcinoma Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Head And Neck Squamous Cell Carcinoma Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Head And Neck Squamous Cell Carcinoma Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Head And Neck Squamous Cell Carcinoma Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Head And Neck Squamous Cell Carcinoma Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Head And Neck Squamous Cell Carcinoma Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Head And Neck Squamous Cell Carcinoma Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Head And Neck Squamous Cell Carcinoma Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Head And Neck Squamous Cell Carcinoma Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Head And Neck Squamous Cell Carcinoma Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Head And Neck Squamous Cell Carcinoma Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Head And Neck Squamous Cell Carcinoma Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Head And Neck Squamous Cell Carcinoma Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Head And Neck Squamous Cell Carcinoma Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Head And Neck Squamous Cell Carcinoma Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Amgen Corporate Summary
Table 31. Amgen Head And Neck Squamous Cell Carcinoma Treatment Product Offerings
Table 32. Amgen Head And Neck Squamous Cell Carcinoma Treatment Revenue (US$, Mn), (2017-2022)
Table 33. AbbVie Corporate Summary
Table 34. AbbVie Head And Neck Squamous Cell Carcinoma Treatment Product Offerings
Table 35. AbbVie Head And Neck Squamous Cell Carcinoma Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Bristol-Myers Squibb Corporate Summary
Table 37. Bristol-Myers Squibb Head And Neck Squamous Cell Carcinoma Treatment Product Offerings
Table 38. Bristol-Myers Squibb Head And Neck Squamous Cell Carcinoma Treatment Revenue (US$, Mn), (2017-2022)
Table 39. AstraZeneca Corporate Summary
Table 40. AstraZeneca Head And Neck Squamous Cell Carcinoma Treatment Product Offerings
Table 41. AstraZeneca Head And Neck Squamous Cell Carcinoma Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Eli Lilly Corporate Summary
Table 43. Eli Lilly Head And Neck Squamous Cell Carcinoma Treatment Product Offerings
Table 44. Eli Lilly Head And Neck Squamous Cell Carcinoma Treatment Revenue (US$, Mn), (2017-2022)
Table 45. GlaxoSmithKline Corporate Summary
Table 46. GlaxoSmithKline Head And Neck Squamous Cell Carcinoma Treatment Product Offerings
Table 47. GlaxoSmithKline Head And Neck Squamous Cell Carcinoma Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Teva Corporate Summary
Table 49. Teva Head And Neck Squamous Cell Carcinoma Treatment Product Offerings
Table 50. Teva Head And Neck Squamous Cell Carcinoma Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Roche Corporate Summary
Table 52. Roche Head And Neck Squamous Cell Carcinoma Treatment Product Offerings
Table 53. Roche Head And Neck Squamous Cell Carcinoma Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Celgene Corporate Summary
Table 55. Celgene Head And Neck Squamous Cell Carcinoma Treatment Product Offerings
Table 56. Celgene Head And Neck Squamous Cell Carcinoma Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Head And Neck Squamous Cell Carcinoma Treatment Segment by Type in 2021
Figure 2. Head And Neck Squamous Cell Carcinoma Treatment Segment by Application in 2021
Figure 3. Global Head And Neck Squamous Cell Carcinoma Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Head And Neck Squamous Cell Carcinoma Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Head And Neck Squamous Cell Carcinoma Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Head And Neck Squamous Cell Carcinoma Treatment Revenue in 2021
Figure 8. By Type - Global Head And Neck Squamous Cell Carcinoma Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Head And Neck Squamous Cell Carcinoma Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Head And Neck Squamous Cell Carcinoma Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Head And Neck Squamous Cell Carcinoma Treatment Revenue Market Share, 2017-2028
Figure 12. US Head And Neck Squamous Cell Carcinoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Head And Neck Squamous Cell Carcinoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Head And Neck Squamous Cell Carcinoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Head And Neck Squamous Cell Carcinoma Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Head And Neck Squamous Cell Carcinoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Head And Neck Squamous Cell Carcinoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Head And Neck Squamous Cell Carcinoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Head And Neck Squamous Cell Carcinoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Head And Neck Squamous Cell Carcinoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Head And Neck Squamous Cell Carcinoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Head And Neck Squamous Cell Carcinoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Head And Neck Squamous Cell Carcinoma Treatment Revenue Market Share, 2017-2028
Figure 24. China Head And Neck Squamous Cell Carcinoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Head And Neck Squamous Cell Carcinoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Head And Neck Squamous Cell Carcinoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Head And Neck Squamous Cell Carcinoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Head And Neck Squamous Cell Carcinoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Head And Neck Squamous Cell Carcinoma Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Head And Neck Squamous Cell Carcinoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Head And Neck Squamous Cell Carcinoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Head And Neck Squamous Cell Carcinoma Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Head And Neck Squamous Cell Carcinoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Head And Neck Squamous Cell Carcinoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Head And Neck Squamous Cell Carcinoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Head And Neck Squamous Cell Carcinoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Amgen Head And Neck Squamous Cell Carcinoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. AbbVie Head And Neck Squamous Cell Carcinoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Bristol-Myers Squibb Head And Neck Squamous Cell Carcinoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. AstraZeneca Head And Neck Squamous Cell Carcinoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Eli Lilly Head And Neck Squamous Cell Carcinoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. GlaxoSmithKline Head And Neck Squamous Cell Carcinoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Teva Head And Neck Squamous Cell Carcinoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Roche Head And Neck Squamous Cell Carcinoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Celgene Head And Neck Squamous Cell Carcinoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)